Cardio Diagnostics Holdings Inc. (CDIO)
Last updated: 2026-10-24 20:40:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Cardio Diagnostics Holdings Inc. (CDIO) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector and is listed on NASDAQ. The stock is currently priced at $1.70, with a market capitalization of $5.05M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.97 to $7.91. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$5.05M | |
$1.80 | |
$255.00 | |
$0.97 | |
$1.71 | |
8.89K | |
37.72K | |
-- | |
$7.91 | |
$0.97 | |
-- | |
-- |
Cardio Diagnostics Holdings Inc. (CDIO) Latest Closing Stock Price
Cardio Diagnostics Holdings Inc. (CDIO) last closed at $1.71 as of 2026-10-23 23:57:00, unchanged from the previous close of $1.71.
During the latest regular trading session, CDIO traded between $0.97 and $255.00, with a volume of 8.89K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Cardio Diagnostics Holdings Inc. (CDIO) 7-Day Stock Price Change
Over the past seven days, Cardio Diagnostics Holdings Inc. (CDIO) moved from $1.76 to $1.70, representing a decline of 3.30% ($0.06).
The stock traded between $1.55 and $1.84 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 26.44 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
CDIO 52-Week Price Position
Position in Range: 10.5%
CDIO is currently trading at $1.70, placing it 10.5% of the way from its 52-week low of $0.97 to its 52-week high of $7.91. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Cardio Diagnostics Holdings Inc. (CDIO)?
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
Cardio Diagnostics Holdings Inc. Information
| Industry | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| Employees | 17 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Cardio Diagnostics Holdings Inc. (CDIO) Stock on MEXC
Eligible investors can buy real shares of Cardio Diagnostics Holdings Inc. (CDIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Cardio Diagnostics Holdings Inc. (CDIO) stock price today?
2.Is CDIO stock going up or down today?
3.What is CDIO pre-market price?
4.What is CDIO after-hours price?
5.Is CDIO stock trading now?
6.Where does CDIO sit relative to its 52-week high and low?
7.What sector is Cardio Diagnostics Holdings Inc. in?
8.What is Cardio Diagnostics Holdings Inc.'s market capitalization and where is it listed?
9.How is CDIO valued in terms of P/E ratio and EPS?
10.Does Cardio Diagnostics Holdings Inc. pay a dividend?
Explore More US Stocks
Search Stocks
CDIO Stock Calculator
Estimate the value between CDIO shares and USD.
CDIO Shares to USD
1.00 CDIO shares = 1.702 USD
Calculations are estimates based on the latest available price and are for reference only.


